Nelson Sun - 14 Feb 2025 Form 4 Insider Report for Aardvark Therapeutics, Inc. (AARD)

Role: Chief Financial Officer
Signature: /s/ Nelson Sun
Issuer symbol: AARD
Transactions as of: 14 Feb 2025
Net transactions value: +$160,000
Form type: 4
Filing time: 19 Feb 2025, 16:30:49 UTC
Previous filing: 12 Feb 2025
Next filing: 13 Jun 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AARD	Common Stock	Conversion of derivative security		+7,001	+8.5%		89,484	14 Feb 2025	Direct	F1
transaction	AARD	Common Stock	Purchase	$160,000	+10,000	+11%	$16.00	99,484	14 Feb 2025	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AARD	Series C Convertible Preferred Stock	Conversion of derivative security	$0	-59,332	-100%	$0.000000	0	14 Feb 2025	Common Stock	7,001		Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Series C Convertible Preferred Stock of Aardvark Therapeutics, Inc. (the "Issuer") automatically converted on an 8.474-for-1 basis into shares of the Issuer's common stock ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. The Series C Convertible Preferred Stock had no expiration date.